Zealand Pharma AS (ZLDPF)
(Delayed Data from OTC)
$50.20 USD
-2.57 (-4.87%)
Updated Aug 5, 2025 01:53 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Zealand Pharma A/S has a market cap of $3.75B, which represents its share price of $52.77 multiplied by its outstanding shares number of 71.02M. As a mid-cap company, ZLDPF's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ZLDPF 50.20 -2.57(-4.87%)
Will ZLDPF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZLDPF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZLDPF
Eli Lilly (LLY) Q1 Earnings Lag Estimates
Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?
ZLDPF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kiniksa Pharmaceuticals, Ltd. (KNSA) Tops Q1 Earnings and Revenue Estimates
Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last?
Zealand Pharma A/S (ZLDPF) Reports Q3 Loss, Lags Revenue Estimates
Other News for ZLDPF
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Zealand Pharma initiated with bullish view at Wells Fargo, here's why
ClearBridge International Growth ACWI Ex-US Strategy Q2 2025 Commentary
Eli Lilly Comes Out As ADA Winner
Zealand Pharma initiated with bullish view at Barclays, here's why